BIIB - BIOGEN INC.
184.02
-4.030 -2.190%
Share volume: 1,049,589
Last Updated: 03-03-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.31%
PREVIOUS CLOSE
CHG
CHG%
$188.05
-4.03
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 04-24-2024 | 08-01-2024 | 10-30-2024 | 02-12-2025 | 05-01-2025 | 07-31-2025 | 10-30-2025 | 02-06-2026 | |
| Assets | |||||||||
| Total Assets | 26.568 B | 26.804 B | 28.313 B | 28.049 B | 28.033 B | 28.330 B | 29.208 B | 29.440 B | |
| Current Assets | 6.756 B | 7.109 B | 6.831 B | 7.457 B | 7.626 B | 7.968 B | 8.937 B | 8.974 B | |
| Inventories | 2.517 B | 2.506 B | 2.469 B | 2.461 B | 2.274 B | 2.274 B | 2.209 B | 2.168 B | |
| Other Current Assets | 1.165 B | 615.300 M | 674.000 M | 1.217 B | 757.300 M | 850.600 M | 916.800 M | 1.648 B | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 97.600 M | 807.200 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 1.074 B | 1.909 B | 1.699 B | 2.375 B | 2.598 B | 2.759 B | 3.863 B | 3.009 B | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 431.900 M | |
| Property Plant Equipment | 3.275 B | 3.249 B | 3.211 B | 3.181 B | 3.132 B | 3.099 B | 3.076 B | 3.055 B | |
| Other Assets | 16.536 B | 16.446 B | 18.272 B | 17.411 B | 17.275 B | 17.264 B | 17.195 B | 17.410 B | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 26.568 B | 26.804 B | 28.313 B | 28.049 B | 28.033 B | 28.330 B | 29.208 B | 29.440 B | |
| Total liabilities | 11.355 B | 10.915 B | 11.954 B | 11.333 B | 11.054 B | 10.696 B | 11.000 B | 11.183 B | |
| Total current liabilities | 3.223 B | 3.108 B | 5.425 B | 5.529 B | 5.297 B | 3.184 B | 3.290 B | 3.349 B | |
| Accounts Payable | 387.000 M | 354.500 M | 422.700 M | 424.200 M | 391.500 M | 408.400 M | 413.100 M | 432.000 M | |
| Other liabilities | 1.184 B | 924.200 M | 1.101 B | 1.067 B | 1.075 B | 1.111 B | 1.067 B | 1.039 B | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 6.290 B | 6.292 B | 4.546 B | 4.547 B | 4.549 B | 6.284 B | 6.285 B | 6.287 B | |
| Other liabilities | 1.184 B | 924.200 M | 1.101 B | 1.067 B | 1.075 B | 1.111 B | 1.067 B | 1.039 B | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 15.213 B | 15.889 B | 16.359 B | 16.716 B | 16.979 B | 17.634 B | 18.208 B | 18.257 B | |
| Common stock | 329.600 M | 407.600 M | 488.600 M | 569.500 M | 630.000 M | 714.100 M | 797.800 M | 863.200 M | |
| Retained earnings | 18.021 B | 18.605 B | 18.993 B | 19.260 B | 19.500 B | 20.135 B | 20.602 B | 20.553 B |